• 1
    Moliterno AR, Spivak JL. Anemia of cancer. Hematol Oncol Clin North Am 1996; 10: 345-63.
  • 2
    Spivak JL. Cancer-related anemia: its causes and characteristics. Semin Oncol 1994; 21: 3-8.
  • 3
    Jatzko GR, Lisborg PH, Denk H, Klimpfinger M, Stettner HM. A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan. Cancer 1995; 76: 1302-12.
  • 4
    Werner Wasik M, Schmid CH, Bornstein L, Ball HG, Smith DM, Madoc Jones H. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma. Int J Radiat Oncol Biol Phys 1995; 32: 1309-17.
  • 5
    Pollack A, Zagars GK, Dinney CP, Swanson DA, von Eschenbach AC. Preoperative radiotherapy for muscle-invasive bladder carcinoma: long term follow-up and prognostic factors for 338 patients. Cancer 1994; 74: 2819-27.
  • 6
    Dunphy EP, Petersen IA, Cox RS, Bagshaw MA. The influence of initial hemoglobin and blood perssure levels on results of radiation therapy for carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1988; 16: 1173-8.
  • 7
    Fein DA, Lee WR, Hanlon AL, Ridge JA, Langer CJ, Curran WJ Jr., et al. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol 1995; 13: 2077-83.
  • 8
    Hong JH, Chen MS, Lin FJ, Tang SG. Prognostic assessment of tumor regression after external irradiation for cervical cancer. Int J Radiat Oncol Biol Phys 1992; 22: 913-7.
  • 9
    Serov SF, Scully RE, Sorbin LH. Histological typing of ovarian tumors. International Histological Classification of Tumors. No. 9. Geneva: World Health Organization, 1973:17.
  • 10
    Day TG, Gallager HS, Rutledge FN. Epithelial carcinoma of the ovary: the prognostic importance of histologic grade. Natl Cancer Inst Monogr 1975; 42: 15-21.
  • 11
    International Federation of Gynecology and Obstetrics. Changes in definitions of clinical staging for carcinoma of the cervix and ovary. Am J Obstet Gynecol 1987; 156: 263-4.
  • 12
    Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1985; 53: 457-81.
  • 13
    Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-70.
  • 14
    Cox DR. Regression models and life tables. J R Stat Soc B 1972; 34: 187-220.
  • 15
    Dische S. Radiotherapy and anemia: the clinical experience. Radiat Oncol 1991; 20(Suppl): 35-40.
  • 16
    Gonzalez Gonzalez D. Hypoxia and local tumour control. Part 1. Radiat Oncol 1991; 20(Suppl): 5-7.
  • 17
    Höckel M, Schlenger K, Aral B, Mitze M, Schäffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996; 56: 4509-15.
  • 18
    Liang BC. Effects of hypoxia on drug resistance phenotype and genotype in human glioma cell lines. J Neurol Oncol 1996; 29: 149-55.
  • 19
    Busch RS. The significance of anemia in clinical radiation therapy. Int J Radiat Oncol Biol Phys 1986; 12: 2047-50.
  • 20
    Leitgeb C, Pecherstorfer M, Fritz E, Ludwig H. Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin. Cancer 1994; 73: 2535-42.
  • 21
    Heiss MM, Mempel W, Delanoff C, Jauch KW, Gabka C, Mempel M, et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogenic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994; 12: 1859-67.
  • 22
    Busch ORC, Hop WCJ, Hoynck van Papendrecht MAW, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993; 328: 1372-6.
  • 23
    Ludwig H, Sundal E, Pecherstorfer M, Leitgeb C, Bauernhofer T, Beinhauer A, et al. Recombinant human erythropoietin for the correction of cancer-associated anemia with and without concomitant cytotoxic chemotherapy. Cancer 1995; 76: 2319-29.
  • 24
    Henry DH, Thatcher N. Patient selection and predicting response to recombinant human erythropoietin in anemic cancer patients. Semin Hematol 1996; 33(1 Suppl 1 ): 2-5.